Gudkov Andrei V 4
4 · CLEVELAND BIOLABS INC · Filed May 18, 2010
Insider Transaction Report
Form 4
Gudkov Andrei V
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2010-05-17$3.56/sh−100$356→ 1,504,800 total - Sale
Common Stock
2010-05-17$3.52/sh−200$704→ 1,509,400 total - Sale
Common Stock
2010-05-17$3.60/sh−900$3,240→ 1,505,490 total - Sale
Common Stock
2010-05-17$3.53/sh−200$706→ 1,504,600 total - Sale
Common Stock
2010-05-17$3.50/sh−3,010$10,535→ 1,506,390 total - Sale
Common Stock
2010-05-17$3.62/sh−300$1,086→ 1,505,190 total - Sale
Common Stock
2010-05-17$3.51/sh−290$1,018→ 1,504,900 total
Holdings
- 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying) - 137,250
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying)
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.3% of the reporting person's 1,549,600 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 3.9% of the reporting person's shares held prior to adoption of the plan.